On February 5, 2018 Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") reported that it will be attending and presenting at the BIO CEO & Investor Conference being held on February 12 – 13, 2018 at the New York Marriott Marquis (Press release, Actinium Pharmaceuticals, FEB 5, 2018, View Source [SID1234523729]). Details of Actinium’s presentation are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, February 13, 2018
Time: 9:15 AM ET
Room: Odets, 4th Floor
Venue: New York Marriott Marquis, 1535 Broadway, New York, NY 10036

Management will be conducting 1-on-1 meetings during the conference. To arrange a meeting with Actinium please contact, Steve O’Loughlin, Actinium’s Principal Financial Officer at [email protected] or utilize the conference’s partnering system View Source